There's news out about CTIC through Financial Wire. Don't have access. Anyone? Could be nothing or the old news of Monday's meeting.
March 24, 2010 (FinancialWire) -- Entest BioMedical (ENTB created three bone marrow-derived stem cell lines useful for optimizing laser intensities and wavelengths in laser enhanced stem cell therapy, with the long-term potential to develop these stem cell lines to create therapies for COPD.
Other recent FinancialWire(tm) news items pertaining to the oncology and stem cell sectors today include Cell Therapeutics, Inc. (CTIC) go to http://www.financialwire.net/?s=%22%28NASDAQ%3A+CTIC%29%22), BioSante Pharmaceuticals, Inc. (BPAX BPAX BIOSANTE PHARMACEUTICALS, INC. 1.87 Change +0.13 (+7.47%) AS OF 4:00 PM ET 03/23/10. Myriad Genetics, Inc. (MYGN Nektar Therapeutics (NKTR Genomic Health, Inc. (GHDX GHDX GENOMIC HEALTH, INC. 18.64 Change -0.16 (-0.85%) AS OF 4:00 PM ET 03/23/10.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.